KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Biogen (BIIB) Inventory Average (2016 - 2025)

Biogen (BIIB) has 17 years of Inventory Average data on record, last reported at $2.2 billion in Q4 2025.

  • For Q4 2025, Inventory Average fell 11.2% year-over-year to $2.2 billion; the TTM value through Dec 2025 reached $2.2 billion, down 11.2%, while the annual FY2025 figure was $2.3 billion, 7.2% down from the prior year.
  • Inventory Average reached $2.2 billion in Q4 2025 per BIIB's latest filing, down from $2.2 billion in the prior quarter.
  • Across five years, Inventory Average topped out at $2.8 billion in Q4 2023 and bottomed at $1.1 billion in Q1 2021.
  • Average Inventory Average over 5 years is $1.8 billion, with a median of $1.8 billion recorded in 2022.
  • Peak YoY movement for Inventory Average: skyrocketed 102.61% in 2023, then dropped 11.2% in 2025.
  • A 5-year view of Inventory Average shows it stood at $1.3 billion in 2021, then increased by 0.74% to $1.4 billion in 2022, then skyrocketed by 102.61% to $2.8 billion in 2023, then fell by 10.53% to $2.5 billion in 2024, then decreased by 11.2% to $2.2 billion in 2025.
  • Per Business Quant database, its latest 3 readings for Inventory Average were $2.2 billion in Q4 2025, $2.2 billion in Q3 2025, and $2.3 billion in Q2 2025.